398 related articles for article (PubMed ID: 25608633)
1. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
Zhang Y; Feng Y; Chen L; Zhu J
Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
[TBL] [Abstract][Full Text] [Related]
3. K
Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
[TBL] [Abstract][Full Text] [Related]
4. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
Freise C; Querfeld U
Pharmacol Res; 2014 Jul; 85():6-14. PubMed ID: 24813858
[TBL] [Abstract][Full Text] [Related]
6. Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer.
Wang ZH; Shen B; Yao HL; Jia YC; Ren J; Feng YJ; Wang YZ
Oncogene; 2007 Aug; 26(35):5107-14. PubMed ID: 17310992
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
[TBL] [Abstract][Full Text] [Related]
8. The role and mechanism of K
Ma XZ; Pang ZD; Wang JH; Song Z; Zhao LM; Du XJ; Deng XL
Exp Cell Res; 2018 Aug; 369(2):208-217. PubMed ID: 29792849
[TBL] [Abstract][Full Text] [Related]
9. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
[TBL] [Abstract][Full Text] [Related]
10. Crocin Improves the Endothelial Function Regulated by Kca3.1 Through ERK and Akt Signaling Pathways.
Yang H; Li X; Liu Y; Li X; Li X; Wu M; Lv X; Chunhua C; Ding X; Zhang Y
Cell Physiol Biochem; 2018; 46(2):765-780. PubMed ID: 29621746
[TBL] [Abstract][Full Text] [Related]
11. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
[TBL] [Abstract][Full Text] [Related]
12. [Intermediate-conductance-Ca2+-activated K+ channels are overexpressed in endometrial cancer and involved in regulating proliferation of endometrial cancer cells].
Wang ZH; Feng YJ; Su M; Yi XF
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):111-5. PubMed ID: 17442186
[TBL] [Abstract][Full Text] [Related]
13. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ -activated K+ channel-3.1 blocker TRAM-34 alleviates murine allergic rhinitis.
Lin H; Zheng C; Li J; Yang C; Hu L
Int Immunopharmacol; 2014 Dec; 23(2):642-8. PubMed ID: 25466273
[TBL] [Abstract][Full Text] [Related]
15. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
[TBL] [Abstract][Full Text] [Related]
16. Functional ion channels and cell proliferation in 3T3-L1 preadipocytes.
Zhang XH; Zhang YY; Sun HY; Jin MW; Li GR
J Cell Physiol; 2012 May; 227(5):1972-9. PubMed ID: 21732368
[TBL] [Abstract][Full Text] [Related]
17. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
[TBL] [Abstract][Full Text] [Related]
18. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
Chen CL; Liao JW; Hu OY; Pao LH
Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
[TBL] [Abstract][Full Text] [Related]
19. Histone Deacetylases Enhance Ca
Matsui M; Terasawa K; Kajikuri J; Kito H; Endo K; Jaikhan P; Suzuki T; Ohya S
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262728
[TBL] [Abstract][Full Text] [Related]
20. Voltage dependence of the Ca(2+)-activated K(+) channel K(Ca)3.1 in human erythroleukemia cells.
Stoneking CJ; Shivakumar O; Thomas DN; Colledge WH; Mason MJ
Am J Physiol Cell Physiol; 2013 May; 304(9):C858-72. PubMed ID: 23407879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
